A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered

- Jackson, Evangeline R., Persson, Mika L., Fish, Cameron J., Findlay, Izac J., Mueller, Sabine, Nazarian, Javad, Hulleman, Esther, van der Lugt, Jasper, Duchatel, Ryan J., Dun, Matthew D.

Assessment of the impact of direct in vitro PFAS treatment on mouse spermatozoa.

- Calvert, Leah, Martin, Jacinta H., Green, Mark P., Nixon, Brett, Anderson, Amanda L., Bernstein, Ilana R., Burke, Nathan D., De Iuliis, Geoffry N., Eamens, Andrew L., Dun, Matthew D., Turner, Brett D., Roman, Shaun D.

Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma

- Arms, Lauren M., Duchatel, Ryan J., Jackson, Evangeline R., Sobrinho, Pedro Garcia, Dun, Matthew D., Hua, Susan

Diffuse midline glioma, H3K27-altered: illuminating the dark side of the moon

- Dun, Matthew D., Odia, Yazmin, Arrillaga-Romany, Isabel

Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement

- Valvi, Santosh, Manoharan, Neevika, Mateos, Marion K., Hassall, Timothy E. G., Ziegler, David S., McCowage, Geoffrey B., Dun, Matthew D., Eisenstat, David D., Gottardo, Nicholas G., Hansford, Jordan R.

Pharmaco-phosphoproteomic analysis of cancer-associated KIT mutations D816V and V560G

- Murray, Heather C., Miller, Kasey, Dun, Matthew D., Verrills, Nicole M.

Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge

- Skerrett-Byrne, David A., Stanger, Simone J., Dun, Matthew D., Pang, Terence Y., Nixon, Brett, Trigg, Natalie A., Anderson, Amanda L., Sipilä, Petra, Bernstein, Ilana R., Lord, Tessa, Schjenken, John E., Murray, Heather C., Verrills, Nicole M.

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Jackson, Evangeline R., Kearney, Padraic S., Jamaluddin, M. Fairuz B., Douglas, Alicia M., Beitaki, Tyrone, McEwen, Holly P., Persson, Mika L., Hocke, Emily A., Jain, Vaibhav, Aksu, Michael, Manning, Elizabeth E., Parackal, Sarah G., Murray, Heather C., Verrills, Nicole M., Hua, Susan, Cairns, Murray J., Alvaro, Frank, Dayas, Christopher V., Dun, Matthew D., Hua, S, de Bock, CE, Colino-Sanguino, Y, Kiltschewskij, Dylan, Valdes-Mora, F, Tsoli, M, Ziegler, DS, Cairns, MJ, Raabe, EH, Vitanza, NA, Hulleman, E, Phoenix, TN, Koschmann, C, Alvaro, F, Findlay, Izac J., Dayas, CV, Tinkle, CL, Wheeler, H, Whittle, JR, Eisenstat, DD, Firestein, R, Mueller, S, Valvi, S, Hansford, JR, Ashley, DM, Mannan, Abdul, Gregory, SG, Kilburn, LB, Nazarian, J, Cain, JE, Dun, MD, Staudt, Dilana E., Thomas, Bryce C., Germon, Zacary P., Laternser, Sandra

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

- de la Nava, Daniel, Ausejo-Mauleon, Iker, Tallon-Cobos, Antonio Carlos, Hernandez-Osuna, Reyes, Marco-Sanz, Javier, Dhandapani, Laasya, Hervás-Corpión, Irati, Becher, Oren J., Nazarian, Javad, Mueller, Sabine, Phoenix, Timothy N., van der Lugt, Jasper, Laspidea, Virginia, Hernaez, Mikel, Guruceaga, E, Koschmann, C, Venneti, S, Allen, JE, Dun, Matthew D., Fueyo, J, Gomez-Manzano, C, Perez-Larraya, JG, Patiño-García, A, Gonzalez-Huarriz, Marisol, Labiano, S, Alonso, MM, Lacalle, Andrea, Casares, Noelia, Zalacain, Marta, Marrodan, Lucía, García-Moure, Marc, Ochoa, Maria C.

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies

- Germon, Zacary P., Sillar, Jonathan R., McLachlan, Tabitha, Schjenken, John E., Skerrett-Byrne, David A., Huang, Honggang, Melo-Braga, Marcella N., Plank, Maximillan W., Alvaro, Frank, Chamberlain, Janis, De Iuliis, Geoff, Aitken, R. John, Mannan, Abdul, Nixon, Brett, Wei, AH, Enjeti, Anoop K., Huang, Y, Lock, RB, Larsen, MR, Lee, Heather, Vaghjiani, V, Cain, JE, de Bock, CE, Duchatel, Ryan J., Verrills, Nicole M., Dun, Matthew D., Staudt, Dilana, Murray, Heather C., Findlay, Izac J., Jackson, Evangeline R., McEwen, Holly P., Douglas, Alicia M.

CAR T cell therapies for diffuse midline glioma

- Thomas, Bryce C., Staudt, Dilana E., Douglas, Alicia M., Monje, Michelle, Vitanza, Nicholas A., Dun, Matthew D.

Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

- Venneti, Sriram, Kawakibi, Abed Rahman, Ramage, Samuel, Chi, Andrew, Wen, Patrick Y., Arrillaga-Romany, Isabel, Batchelor, Tracy T., Butowski, Nicholas A., Sumrall, Ashley, Shonka, Nicole, Harrison, Rebecca A., de Groot, John, Ji, Sunjong, Mehta, M, Hall, MD, Daghistani, D, Cloughesy, TF, Ellingson, BM, Beccaria, K, Varlet, P, Kim, MM, Umemura, Y, Garton, H, Waszak, Sebastian M., Franson, A, Schwartz, J, Jain, R, Kachman, M, Baum, H, Burant, CF, Mottl, SL, Cartaxo, RT, John, V, Messinger, D, Sweha, StefanR, Qin, T, Peterson, E, Sajjakulnukit, P, Ravi, K, Waugh, A, Walling, D, Ding, Y, Xia, Z, Schwendeman, A, Hawes, D, Mota, Mateus, Yang, F, Judkins, AR, Wahl, D, Lyssiotis, CA, de la Nava, D, Alonso, MM, Eze, A, Spitzer, J, Schmidt, SV, Duchatel, Ryan J., Pun, Matthew, Dun, Matthew D., Cain, JE, Jiang, L, Stopka, SA, Baquer, G, Regan, MS, Filbin, MG, Agar, NYR, Zhao, L, Kumar-Sinha, C, Deogharkar, Akash, Mody, R, Chinnaiyan, A, Kurokawa, R, Pratt, D, Yadav, VN, Grill, J, Kline, C, Mueller, S, Resnick, A, Nazarian, J, Chung, Chan, Allen, JE, Odia, Y, Gardner, SL, Koschmann, C, Tarapore, Rohinton S.

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia

- Humphries, Sam, Bond, Danielle R., Germon, Zacary P., Keely, Simon, Enjeti, Anoop K., Dun, Matthew D., Lee, Heather J.

Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities

- Sun, Claire Xin, Daniel, Paul, Adjumain, Shazia, Sun, Christie, Chong, Wai Chin, Fernando, Dasun, Drinkwater, Caroline, Tourchi, Motahhareh, Habarakada, Dilru, Sooraj, Dhanya, Carvalho, Diana, Storm, Phillip B., Bradshaw, Gabrielle, Baubet, Valerie, Sayles, LC, Fernandez, E, Nguyen, T, Pörksen, M, Doan, A, Crombie, DE, Panday, M, Zhukova, N, Dun, Matthew D., Shi, Hui, Ludlow, LE, Day, B, Stringer, BW, Neeman, N, Rubens, JA, Raabe, EH, Vinci, M, Tyrrell, V, Fletcher, JI, Ekert, PG, Loi, Melissa, Dumevska, B, Ziegler, DS, Tsoli, M, Syed Sulaiman, NF, Loh, AHP, Low, SYY, Sweet-Cordero, EA, Monje, M, Resnick, A, Jones, C, Chew, Nicole, Downie, P, Williams, B, Rosenbluh, J, Gough, D, Cain, JE, Firestein, R, Parackal, Sarah, Tsui, Vanessa, Liang, Yuqing, Koptyra, Mateusz

Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia

- Murray, Heather C., Miller, Kasey, Brzozowski, Joshua S., Kahl, Richard G. S., Smith, Nathan D., Humphrey, Sean J., Dun, Matthew D., Verrills, Nicole M.

Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.

- Noll, Alyssa, Myers, Carrie, Winter, Conrad, Pakiam, Fiona, Leary, Sarah E. S., Cole, Bonnie L., Jackson, Evangeline R., Dun, Matthew D., Foster, Jessica B., Evans, Myron K., Pattwell, Siobhan S., Olson, James M., Biery, Matthew C., Vitanza, Nicholas A., Meechan, Michael, Tahiri, Sophie, Rajendran, Asmitha, Berens, Michael E., Paine, Danyelle, Byron, Sara, Zhang, Jiaming

Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma

- Messinger, Dana, Harris, Micah K., Qin, Tingting, Mullan, Brendan, Siada, Ruby, Ravindran, Ramya, Niculcea, Michael, Dowling, Abigail R., Bradin, Joshua, Ginn, Kevin F., Gener, Melissa A. H., Dorris, Kathleen, Cummings, Jessica R., Vitanza, Nicholas A., Schmidt, SV, Spitzer, J, Li, J, Filbin, MG, Cao, X, Castro, MG, Lowenstein, PR, Mody, R, Chinnaiyan, A, Thomas, Chase, Desprez, PY, McAllister, S, Dun, Matthew D., Hawkins, C, Waszak, SM, Venneti, S, Koschmann, C, Yadav, VN, Yang, Tao, Sweha, Stefan R., Woo, Rinette, Siddaway, Robert, Burkert, Martin, Stallard, Stefanie

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

- Foster, Jessica B., Alonso, Marta M., Sayour, Elias, Davidson, Tom B., Persson, Mika L., Dun, Matthew D., Kline, Cassie, Mueller, Sabine, Vitanza, Nicholas A., van der Lugt, Jasper

Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans

- Calvert, Leah, Green, Mark P., De Iuliis, Geoffry N., Dun, Matthew D., Turner, Brett D., Clarke, Bradley O., Eamens, Andrew L., Roman, Shaun D., Nixon, Brett

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers

- McLachlan, Tabitha, Matthews, William C., Dun, Matthew D., Jackson, Evangeline R., Staudt, Dilana E., Douglas, Alicia M., Findlay, Izac J., Persson, Mika L., Duchatel, Ryan J., Mannan, Abdul, Germon, Zacary P.